TickerFactsScreenerDevelopers

Lineage Cell Therapeutics, Inc. (LCTX) — Total Assets

Annual figures by fiscal year, from SEC filings.

2010: $53.27M2011: $45.83M2012: $29.75M2013: $57.73M2014: $74.90M2015: $94.66M2016: $142.57M2017: $173.24M2018: $101.66M2019: $125.48M2020: $107.95M2021: $174.54M2022: $123.66M2023: $101.02M2024: $113.22M2025: $112.58M$112.58M
2010Total Assets (USD)2025
Fiscal YearTotal AssetsChange YoY
2025$112.58M-0.6%
2024$113.22M+12.1%
2023$101.02M-18.3%
2022$123.66M-29.2%
2021$174.54M+61.7%
2020$107.95M-14.0%
2019$125.48M+23.4%
2018$101.66M-41.3%
2017$173.24M+21.5%
2016$142.57M+50.6%
2015$94.66M+26.4%
2014$74.90M+29.7%
2013$57.73M+94.1%
2012$29.75M-35.1%
2011$45.83M-14.0%
2010$53.27M—